Welcome to our dedicated page for Altria Group news (Ticker: MO), a resource for investors and traders seeking the latest updates and insights on Altria Group stock.
Altria Group, Inc. (MO) generates a steady flow of news through its financial results, product updates, capital allocation decisions and corporate governance actions. As a U.S. tobacco manufacturing company with both combustible and smoke-free products, Altria regularly issues press releases and files current reports that provide insight into its operations, portfolio and strategic direction.
Investors following MO news can expect detailed earnings announcements covering quarterly and year-to-date performance, including net revenues, earnings per share metrics and commentary on segment trends in smokeable and oral tobacco products. These releases often discuss factors affecting results, such as pricing, volume, special items, and the performance of brands like on! within the oral tobacco segment.
Altria’s news flow also highlights capital returns and financing activity. The company frequently announces regular quarterly dividends and dividend increases, as well as share repurchase activity and changes to its share repurchase program authorization. In addition, it discloses debt offerings and related agreements through press releases and Form 8-K filings, outlining new senior unsecured notes and credit facility amendments.
Corporate and strategic developments are another key news category. Altria reports on leadership and Board changes, including CEO succession plans, future appointments to executive roles and the planned retirement of directors. It also issues updates on its smoke-free strategy, such as product launches in oral nicotine pouches, regulatory submissions for heated tobacco sticks and collaboration agreements, including its memorandum of understanding with KT&G Corporation for modern oral and non-nicotine opportunities.
This MO news page helps readers track these disclosures in one place, from dividend declarations and webcast announcements to strategic partnerships and regulatory milestones. Regular review of Altria’s news can provide context for the company’s financial performance, portfolio evolution and governance decisions.
Altria Group (NYSE: MO) reported its Q4 and full-year 2024 results, providing guidance for 2025. Key highlights include:
- Q4 2024 net revenues reached $5,974M (flat YoY), with adjusted diluted EPS of $1.29 (+9.3%)
- Full-year 2024 net revenues were $24,018M (-1.9% YoY), with adjusted diluted EPS of $5.12 (+3.4%)
- NJOY's Q4 performance showed strong growth with consumables shipment volume up 15.3% to 12.8M units and retail share reaching 6.4%
The company announced a new $1 billion share repurchase program to be completed by December 2025, after completing its previous $3.4B program. For 2025, Altria expects adjusted diluted EPS of $5.22-$5.37, representing 2-5% growth from 2024's $5.12 base.
Notable challenges include ITC's final determination in JUUL's case against NJOY, potentially affecting ACE product sales from March 31, 2025, and significant market presence of illicit e-vapor products, estimated at over 60% of the category.
Altria Group (NYSE: MO) has announced it will host a live audio webcast to discuss its 2024 fourth-quarter and full-year business results on Thursday, January 30, 2025, at 9:00 a.m. Eastern Time. The company will release its business results press release earlier the same day at approximately 7:00 a.m. Eastern Time.
The webcast will feature CEO Billy Gifford and CFO Sal Mancuso, who will present the results and address questions from the investment community and news media. The event will be in listen-only mode and requires pre-registration through www.altria.com/webcasts. An archived version of the webcast will be available on altria.com following the event.
Altria Group (NYSE: MO) has announced that its Board of Directors has declared a regular quarterly dividend of $1.02 per share. The dividend will be paid on January 10, 2025, to shareholders of record as of December 26, 2024. The ex-dividend date is also set for December 26, 2024.
Altria Group (NYSE: MO) reported Q3 2024 results with net revenues of $6,259 million, down 0.4% year-over-year. The company reaffirmed its 2024 full-year adjusted diluted EPS guidance of $5.07 to $5.15, representing 2.5% to 4% growth from 2023. Key highlights include solid performance in smokeable products, continued momentum of NJOY with 15.6% increase in consumables shipment volume, and announcement of an Optimize & Accelerate initiative expected to deliver $600 million in cost savings over five years. The company returned value to shareholders through $680 million in share repurchases and increased its quarterly dividend by 4.1%.
Altria Group, Inc. (NYSE: MO) has announced a live audio webcast scheduled for Thursday, October 31, 2024, at 9:00 a.m. Eastern Time. The webcast will cover Altria's 2024 third-quarter and nine-months business results. A press release detailing these results will be issued at approximately 7:00 a.m. Eastern Time on the same day.
The webcast, accessible at altria.com, will feature Billy Gifford, Altria's CEO, and Sal Mancuso, Altria's CFO, who will discuss the company's performance and address questions from the investment community and news media. The event will be in listen-only mode and requires pre-event registration, with directions available at www.altria.com/webcasts. An archived version of the webcast will be made available on Altria's website afterward.
Altria Group, Inc. (NYSE: MO) and NJOY respond to an initial determination by the U.S. International Trade Commission (ITC) Administrative Law Judge regarding JUUL Labs' patent infringement complaint against NJOY. The judge recommended an exclusion order to prohibit NJOY ACE importation into the U.S. Altria and NJOY disagree with this determination and await the full ITC's final decision by December 23, 2024.
NJOY filed a similar complaint against JUUL in August 2023, with a hearing held in June 2024 and an initial determination expected in September. The parties are engaged in mediation to resolve these disputes. NJOY has also filed Substantial Equivalence Exemption requests with the FDA for a modified ACE product to avoid patent issues.
An exclusion order on ACE, the first FDA-authorized pod-based e-vapor product, could limit choices for adult smokers and impact public health efforts.
Altria Group, Inc. (NYSE: MO) has announced a 4.1% increase in its regular quarterly dividend, raising it from $0.98 to $1.02 per share. The new dividend is payable on October 10, 2024, to shareholders of record as of September 16, 2024. This increase aligns with Altria's progressive dividend goal, targeting mid-single digits dividend per share growth annually through 2028. The new annualized dividend rate is $4.08 per share, representing a dividend yield of 7.9% based on the closing stock price of $51.81 on August 21, 2024. This marks Altria's 59th dividend increase in 55 years, demonstrating the company's commitment to shareholder returns.
Altria Group (NYSE: MO) reported its Q2 and H1 2024 results, narrowing full-year adjusted EPS guidance to $5.07-$5.15, representing 2.5-4% growth from 2023. Q2 net revenues decreased 4.6% to $6,209 million, while adjusted diluted EPS remained flat at $1.31. H1 adjusted diluted EPS declined 1.6% to $2.46.
Key highlights:
- NJOY e-vapor products gained market share, reaching 5.5% in Q2
- NJOY received FDA authorization for menthol e-vapor products
- Completed $2.4 billion accelerated share repurchase program
- Paid $3.4 billion in dividends during H1 2024
Altria continues to invest in smoke-free products while maintaining resilient traditional tobacco businesses. The company expects stronger EPS growth in H2 2024.
Altria Group (NYSE: MO) has announced it will host a live audio webcast on July 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 second-quarter and first-half business results. The company will release a press release with the results at approximately 7:00 a.m. Eastern Time on the same day. CEO Billy Gifford and CFO Sal Mancuso will lead the discussion and answer questions from investors and media. The webcast will be in listen-only mode and requires pre-event registration. An archived version will be available on Altria's website after the event.
Altria Group announced the submission of Premarket Tobacco Product Applications (PMTAs) to the FDA for its new on! PLUS oral nicotine pouches. Developed by Helix Innovations, these pouches are made from a proprietary soft-feel material for a more comfortable user experience. On! PLUS pouches, designed for adult dippers and dual users, come in tobacco, mint, and wintergreen flavors with three nicotine strength options. Altria believes the product will significantly contribute to Helix's growth upon FDA authorization. In Q1 2024, on! pouches saw a 32% increase in shipment volume and captured a 7.1% market share in the U.S. oral tobacco category.